These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03% dermatologic ointment. Sakarya Y, Sakarya R. J Ocul Pharmacol Ther; 2012 Feb; 28(1):94-6. PubMed ID: 22103968 [Abstract] [Full Text] [Related]
3. [FK 506 ointment 0.1 % - A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients]. Mayer K, Reinhard T, Reis A, Böhringer D, Sundmacher R. Klin Monbl Augenheilkd; 2001 Nov; 218(11):733-6. PubMed ID: 11731901 [Abstract] [Full Text] [Related]
4. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. Perry HD, Doshi-Carnevale S, Donnenfeld ED, Solomon R, Biser SA, Bloom AH. Cornea; 2006 Feb; 25(2):171-5. PubMed ID: 16371776 [Abstract] [Full Text] [Related]
6. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study. Virtanen HM, Reitamo S, Kari M, Kari O. Acta Ophthalmol Scand; 2006 Oct; 84(5):693-5. PubMed ID: 16965503 [Abstract] [Full Text] [Related]
7. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders. Joseph MA, Kaufman HE, Insler M. Cornea; 2005 May; 24(4):417-20. PubMed ID: 15829797 [Abstract] [Full Text] [Related]
8. Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial. Corrocher G, Di Lorenzo G, Mansueto P, Martinelli N, Esposito-Pellitteri M, Gelio S, Lombardo G, Pacor ML. Clin Ther; 2006 Sep; 28(9):1296-302. PubMed ID: 17062302 [Abstract] [Full Text] [Related]
9. Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis. Opitz DL, Tyler KF. Clin Exp Optom; 2011 Mar; 94(2):200-6. PubMed ID: 21083761 [Abstract] [Full Text] [Related]
10. [Bibrocathol eye ointment is efficacious in blepharitis. Results from a randomized, double-blind, controlled clinical trial]. Behrens-Baumann W, Niederdellmann C, Jehkul A, Kohnen R. Ophthalmologe; 2006 Nov; 103(11):960-5. PubMed ID: 17003947 [Abstract] [Full Text] [Related]
11. Efficacy and safety of topical azithromycin therapy in patients with blepharitis and meibomian gland dysfunction. Shimazaki J, Kito G, Kamoi M, Satake Y. Jpn J Ophthalmol; 2024 Sep; 68(5):472-481. PubMed ID: 39002075 [Abstract] [Full Text] [Related]
12. Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. Nivenius E, van der Ploeg I, Jung K, Chryssanthou E, van Hage M, Montan PG. Eye (Lond); 2007 Jul; 21(7):968-75. PubMed ID: 16680103 [Abstract] [Full Text] [Related]
13. Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases. Lee YJ, Kim SW, Seo KY. Am J Ophthalmol; 2013 May; 155(5):804-13. PubMed ID: 23394907 [Abstract] [Full Text] [Related]
14. The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy. Matsumoto Y, Shigeno Y, Sato EA, Ibrahim OM, Saiki M, Negishi K, Ogawa Y, Dogru M, Tsubota K. Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):821-9. PubMed ID: 19101718 [Abstract] [Full Text] [Related]
15. Clinical safety and efficacy of vitamin D3 analog ointment for treatment of obstructive meibomian gland dysfunction. Arita R, Kawashima M, Ito M, Tsubota K. BMC Ophthalmol; 2017 Jun 07; 17(1):84. PubMed ID: 28592257 [Abstract] [Full Text] [Related]
16. Tacrolimus ointment in atopic blepharoconjunctivitis does not seem to elevate intraocular pressure. Remitz A, Virtanen HM, Reitamo S, Kari O. Acta Ophthalmol; 2011 May 07; 89(3):e295-6. PubMed ID: 20064110 [No Abstract] [Full Text] [Related]
17. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Reitamo S, Harper J, Bos JD, Cambazard F, Bruijnzeel-Koomen C, Valk P, Smith C, Moss C, Dobozy A, Palatsi R, European Tacrolimus Ointment Group. Br J Dermatol; 2004 Mar 07; 150(3):554-62. PubMed ID: 15030341 [Abstract] [Full Text] [Related]